Publications by authors named "Raphael Itzykson"

88Publications

Contemporary treatment approaches to CMML - Is allogeneic HCT the only cure?

Best Pract Res Clin Haematol 2020 06 30;33(2):101138. Epub 2019 Dec 30.

Département D'Hématologie Immunologie, Service Hématologie-Greffe, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France; Université de Paris, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, F-75010, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2019.101138DOI Listing
June 2020

Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?

Biol Blood Marrow Transplant 2020 Jun 28;26(6):1160-1170. Epub 2020 Feb 28.

Hematology and Transplantation, Saint Louis Hospital, Paris, France; University of Paris, INSERM U976, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.02.019DOI Listing
June 2020

BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias.

Leuk Res 2019 12 7;87:106269. Epub 2019 Nov 7.

INSERM/CNRS UMR 944/7212, Paris, France; Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité, Paris Cancer Research Institute (PACRI), Paris, France; Département d'Hématologie, Hôpital Saint-Louis, Assistance Publique - Hopitaux de Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.106269DOI Listing
December 2019

Clinical update on hypomethylating agents.

Int J Hematol 2019 Aug 24;110(2):161-169. Epub 2019 Apr 24.

INSERM/CNRS UMR 944/7212, Saint-Louis Research Institute, Paris Diderot University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-019-02651-9DOI Listing
August 2019

The fraction of CD117/c-KIT-expressing erythroid precursors predicts ESA response in low-risk myelodysplastic syndromes.

Cytometry B Clin Cytom 2019 05 9;96(3):215-222. Epub 2019 Apr 9.

Service d'Hématologie-Immunologie-Transfusion, Hôpitaux Universitaires Paris Ile de France Ouest, Boulogne 92100, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21781DOI Listing
May 2019

New Treatment Options for Acute Myeloid Leukemia in 2019.

Curr Oncol Rep 2019 02 4;21(2):16. Epub 2019 Feb 4.

Department of Hematology, Hopital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris Diderot University, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-019-0764-8
Publisher Site
http://dx.doi.org/10.1007/s11912-019-0764-8DOI Listing
February 2019

Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study.

Ann Hematol 2019 Apr 23;98(4):1033-1035. Epub 2018 Oct 23.

Service d'hématologie-greffe, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, 1 avenue Claude Vellefaux, 75475, Paris, Cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3530-3DOI Listing
April 2019

CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.

Br J Haematol 2019 02 10;184(4):625-633. Epub 2018 Sep 10.

Service d'Hématologie-Immunologie-Transfusion, Hôpitaux Universitaires Paris Ile De France Ouest, Université Versailles Saint Quentin, Boulogne, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.15584
Publisher Site
http://dx.doi.org/10.1111/bjh.15584DOI Listing
February 2019

How and when to decide between epigenetic therapy and chemotherapy in patients with AML.

Hematology Am Soc Hematol Educ Program 2017 12;2017(1):45-53

Hôpital Saint-Louis, Institut Universitaire d'Hématologie, Université Paris Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2017.1.45DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142607PMC
December 2017

How I treat chronic myelomonocytic leukemia.

Blood 2017 07 1;130(2):126-136. Epub 2017 Jun 1.

Department of Hematology, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Université Paris Diderot, Paris, France.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2017-04
Publisher Site
http://dx.doi.org/10.1182/blood-2017-04-736421DOI Listing
July 2017

CMML: Clinical and molecular aspects.

Int J Hematol 2017 Jun 28;105(6):711-719. Epub 2017 Apr 28.

INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-017-2243-zDOI Listing
June 2017

Choosing a hypomethylating agent in MDS: does gender matter?

Leuk Lymphoma 2017 06 31;58(6):1277-1278. Epub 2017 Jan 31.

b Service d'Hématologie Adultes , Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Université Paris Diderot , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1283035DOI Listing
June 2017

New therapeutic approaches in myelodysplastic syndromes: Hypomethylating agents and lenalidomide.

Exp Hematol 2015 Aug 27;43(8):661-72. Epub 2015 Jun 27.

Department of Hematology, Saint-Louis Hospital, Assistance Publique, Hopitaux de Paris, Paris Diderot University, Paris, France; Institut National de la Santé et de la Recherche Médicale, Saint-Louis Institute, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2015.05.014DOI Listing
August 2015

Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation.

Haematologica 2015 Jan 26;100(1):114-23. Epub 2014 Sep 26.

Service d'Hématologie Greffe, Hôpital Saint-Louis, APHP, Paris Université Paris-Diderot et Paris Sorbonne Cité Inserm UMRS-1160, Institut Universitaire d'Hématologie, Paris

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.113415DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281324PMC
January 2015

Alemtuzumab for severe steroid-refractory gastrointestinal acute graft-versus-host disease.

Biol Blood Marrow Transplant 2014 Sep 6;20(9):1451-4. Epub 2014 Jun 6.

Clinique d'hématologie, CHU de Grenoble, UMR 5525 CNRS-UJF, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.031DOI Listing
September 2014

Myelodysplastic syndromes.

Lancet 2014 Jun 21;383(9936):2239-52. Epub 2014 Mar 21.

Service d'hématologie, Hôpital St Louis (Assistance Publique Hôpitaux de Paris) and Paris 7 University, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(13)61901-7DOI Listing
June 2014

Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia.

Am J Hematol 2014 Jun 10;89(6):604-9. Epub 2014 Apr 10.

Centre de Recherche en Cancérologie de Marseille, Aix-Marseille University, Marseille, France; Laboratoire d'Oncologie Moléculaire, UMR1068 Inserm, CNRS UMR7258, Aix-Marseille University, Marseille, France; Institut Paoli-Calmettes, Aix-Marseille University, Marseille, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.23702
Publisher Site
http://dx.doi.org/10.1002/ajh.23702DOI Listing
June 2014

Chronic myelomonocytic leukemia: myelodysplastic or myeloproliferative?

Best Pract Res Clin Haematol 2013 Dec 1;26(4):387-400. Epub 2013 Oct 1.

Inserm UMR 1009, Institut Gustave Roussy, 14 rue Edouard Vaillant, 94805 Villejuif cedex, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2013.09.006DOI Listing
December 2013

Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes.

Best Pract Res Clin Haematol 2013 Dec 13;26(4):355-64. Epub 2014 Jan 13.

Hematology Department, Hôpital Saint-Louis, Assistance Publique - Hôpitaux de Paris (AP-HP), France; Université Paris 7, France; INSERM UMR-S-940, Hôpital St Louis, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.01.001DOI Listing
December 2013

A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages.

Biochim Biophys Acta 2013 Aug 17;1833(8):1936-46. Epub 2013 Apr 17.

Faculté de Médecine, Université de Bourgogne, Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2013.04.007DOI Listing
August 2013

Treatment of advanced myelodysplastic syndrome with demethylating agents: azacitidine.

Semin Hematol 2012 Oct;49(4):323-9

Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Service d'hématologie clinique, Paris 13 university, Bobigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2012.09.002DOI Listing
October 2012

MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations.

Blood 2012 Sep 7;120(13):2719-22. Epub 2012 Jun 7.

Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche (UMR) 1009, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-04-422352DOI Listing
September 2012

Optimizing hypomethylating agents in myelodysplastic syndromes.

Curr Opin Hematol 2012 Mar;19(2):65-70

Service D'hématologie Clinique, Hôpital Avicenne, Bobigny and Institut Gustave-Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOH.0b013e32834ff58aDOI Listing
March 2012

Predicting the outcome of patients with higher-risk myelodysplastic syndrome treated with hypomethylating agents.

Leuk Lymphoma 2012 May 31;53(5):760-2. Epub 2012 Jan 31.

Service d' hématologie clinique, Hôpital Avicenne and Institut Gustave-Roussy, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.651618DOI Listing
May 2012

[Hypomethylating agents for the treatment of myelodysplastic syndromes].

Bull Cancer 2011 Aug;98(8):927-34

Institut Gustave-Roussy, Villejuif, France, Hôpital Avicenne, service d'hématologie clinique, Bobigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2011.1411DOI Listing
August 2011

Bleeding in patients with Budd-Chiari syndrome.

J Hepatol 2011 Jan 20;54(1):56-63. Epub 2010 Aug 20.

Pôle des Maladies de l'Appareil Digestif, Service d'Hépatologie, Hôpital Beaujon, AP-HP, Clichy, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2010.06.019DOI Listing
January 2011

Optimal sequencing of treatments for patients with myelodysplastic syndromes.

Curr Opin Hematol 2009 Mar;16(2):77-83

Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Paris University, Bobigny, France.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00062752-200903000-000
Publisher Site
http://dx.doi.org/10.1097/MOH.0b013e3283257a74DOI Listing
March 2009

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.

Cell 2004 Jun;117(7):927-39

Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2004.06.006DOI Listing
June 2004